Lilly moved first. In January 2024, it launched LillyDirect, linking patients with telehealth providers and home delivery for its diabetes and weight-management portfolio. Pfizer followed in August ...

Once a niche asset class serving grocers and food processors, cold storage has evolved into one of the most dynamic, data-driven, and capital-intensive property types in commercial real estate.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

A Shocking Reality The fashion industry's relationship with body diversity is like a bad breakup – it keeps promising change ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price innovation. It underscores the fragility of international reference pricing ...

Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...

Ozempic has taken TikTok by storm. It’s hailed as a miracle weight loss drug that helps you shed the pounds without even really trying. Sound too good to be true? Well, it could be. There’s lots of ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but ...